RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.941
-0.009 (-0.92%)
At close: Dec 5, 2025, 4:00 PM EST
0.990
+0.049 (5.17%)
After-hours: Dec 5, 2025, 6:40 PM EST
RenovoRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 0.93 | 0.04 | - | - | - | - | |
| Gross Profit | 0.63 | 0.04 | - | - | - | - | |
| Selling, General & Admin | 5.91 | 4.99 | 5.73 | 5.65 | 2.63 | 0.82 | |
| Research & Development | 6.34 | 6.03 | 5.67 | 4.3 | 3.04 | 2.39 | |
| Operating Expenses | 12.25 | 11.01 | 11.4 | 9.95 | 5.67 | 3.2 | |
| Operating Income | -11.62 | -10.97 | -11.4 | -9.95 | -5.67 | -3.2 | |
| Interest Expense | - | - | - | - | -0.83 | -0.59 | |
| Interest & Investment Income | 0.44 | 0.38 | 0.11 | 0.06 | - | - | |
| Other Non Operating Income (Expenses) | 0.08 | 1.77 | 1.06 | 0 | 0.12 | -0.01 | |
| EBT Excluding Unusual Items | -11.11 | -8.81 | -10.23 | -9.89 | -6.39 | -3.8 | |
| Other Unusual Items | - | - | - | - | 0.06 | - | |
| Pretax Income | -11.11 | -8.81 | -10.23 | -9.89 | -6.32 | -3.8 | |
| Net Income | -11.11 | -8.81 | -10.23 | -9.89 | -6.32 | -3.8 | |
| Net Income to Common | -11.11 | -8.81 | -10.23 | -9.89 | -6.32 | -3.8 | |
| Shares Outstanding (Basic) | 32 | 22 | 10 | 9 | 5 | 2 | |
| Shares Outstanding (Diluted) | 32 | 22 | 10 | 9 | 5 | 2 | |
| Shares Change (YoY) | 73.80% | 116.42% | 13.69% | 73.50% | 135.64% | 1.69% | |
| EPS (Basic) | -0.34 | -0.40 | -0.99 | -1.09 | -1.21 | -1.72 | |
| EPS (Diluted) | -0.34 | -0.40 | -0.99 | -1.09 | -1.21 | -1.72 | |
| Free Cash Flow | -10.4 | -9.14 | -10.26 | -8.81 | -5.93 | -3.53 | |
| Free Cash Flow Per Share | -0.32 | -0.41 | -1.00 | -0.97 | -1.14 | -1.59 | |
| Gross Margin | 67.78% | 100.00% | - | - | - | - | |
| Operating Margin | -1252.15% | -25511.63% | - | - | - | - | |
| Profit Margin | -1196.66% | -20497.67% | - | - | - | - | |
| Free Cash Flow Margin | -1120.37% | -21248.84% | - | - | - | - | |
| EBITDA | - | - | -11.39 | -9.94 | -5.66 | - | |
| D&A For EBITDA | - | - | 0.01 | 0.01 | 0.01 | - | |
| EBIT | -11.62 | -10.97 | -11.4 | -9.95 | -5.67 | -3.2 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.